Medicus Pharma Ltd. (NASDAQ:MDCX – Get Free Report)’s share price dropped 1.4% on Friday . The stock traded as low as $2.60 and last traded at $2.80. Approximately 26,989 shares traded hands during trading, an increase of 138% from the average daily volume of 11,341 shares. The stock had previously closed at $2.84.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on MDCX shares. Maxim Group assumed coverage on Medicus Pharma in a research report on Tuesday, December 17th. They issued a “buy” rating and a $10.00 target price for the company. Brookline Capital Management raised Medicus Pharma to a “strong-buy” rating in a research note on Monday, December 23rd.
Read Our Latest Stock Analysis on Medicus Pharma
Medicus Pharma Stock Down 1.4 %
Medicus Pharma (NASDAQ:MDCX – Get Free Report) last announced its earnings results on Friday, November 22nd. The company reported ($0.31) earnings per share (EPS) for the quarter. On average, analysts expect that Medicus Pharma Ltd. will post -1.14 earnings per share for the current fiscal year.
Medicus Pharma Company Profile
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
Featured Articles
- Five stocks we like better than Medicus Pharma
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- 5 Top Rated Dividend Stocks to Consider
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
